Abstract
Mechanisms of macrophage polarization towards M1 phenotype or M2 phenotype, as well as of macrophage transformation into foam cells upon interaction with mycobacteria, are discussed. The possible effects of Mycobacterium tuberculosis (Mtb) on macrophage polarization and activation are analyzed. The role of different cell-death pathways (apoptosis, necrosis, and autophagy) in mycobacteria persistence in vitro and in vivo is elucidated. The most likely means of macrophage reprogramming to increase their microbicidal activity for the purpose of tuberculosis treatment and prevention are analyzed.
Similar content being viewed by others
References
Aguilo, N., Marinova, D., Martin, C., and Pardo, J., ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question, Front. Cell. Infect. Microbiol., 2013, vol. 3, art. 88, pp. 1–7.
Almeida, P.E., Carneiro, A.B., Silva, A.R., and Bozza, P.T., PPAR? expression and function in Mycobacterial infection: roles in lipid metabolism, immunity, and bacterial killing, PPAR Res., 2012, vol. 2012, pp. 1–7.
Almeida, P.E., Roque, N.R., Magalhaes, K.G., et al., Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection, Biochim. Biophys. Acta, 2014, vol. 1841, pp. 97–107.
Almeida, P.E., Silva, A.R., Maya-Monteiro, C.M., et al., Mycobacterium bovis bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor I expression and activation: functions in inflammation, lipid metabolism, and pathogenesis, J. Immunol., 2009, vol. 183, pp. 1337–1345.
Ashida, H., Mimuro, H., Ogawa, M., et al., Cell death and infection: a double-edged sword for host and pathogen survival, J. Cell Biol., 2011, vol. 195, pp. 931–942.
Averbakh, M.M., Tuberculous granuloma: modern insight on immunogenesis and cell content, Tuberk. Bolezni Legk., 2010, vol. 87, no. 6, pp. 3–9.
Bafica, A., Scanga, C.A., Feng, C.G., et al., TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis, J. Exp. Med., 2005, vol. 202, pp. 1715–1724.
Bai, X., Feldman, N.E., Chmura, K., et al., Inhibition of nuclear factor-kappa B activation decreases survival of Mycobacterium tuberculosis in human macrophages, PLoS One, 2013, vol. 8, pp. e61925.
Banerjee, D. and Bhattacharyya, R., Statin therapy may prevent development of tuberculosis in diabetic state, Med. Hypotheses, 2014, vol. 83, pp. 88–91.
Battersby, A.J., Kampmann, B., and Burl, S., Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis, Clin. Dev. Immunol., 2012, vol. 2012, pp. 1–10.
Behar, S.M., Divangahi, M., and Remold, H.G., Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat. Rev. Microbiol., 2010, vol. 8, pp. 668–674.
Bonilla, D.L., Bhattacharya, A., Sha, Y., et al., Autophagy regulates phagocytosis by modulating the expression of scavenger receptors, Immunity, 2013, vol. 39, pp. 537–547.
Bos, K.I., Harkins, K.M., Herbig, A., et al., Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis, Nature, 2014, vol. 514, pp. 494–497.
Briken, V., Mycobacterium tuberculosis genes involved in regulation of host cell death, Adv. Exp. Med. Biol., 2013, vol. 783, pp. 93–102.
Briken, V. and Miller, J.L., Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis, Future Microbiol., 2008, vol. 3, pp. 415–422.
Brune, B., Dehne, N., Grossmann, N., et al., Redox control of inflammation in macrophages, Antioxid. Redox Signaling, 2013, vol. 19, pp. 595–637.
Cabal-Hierro, L. and Lazo, P.S., Signal transduction by tumor necrosis factor receptors, Cell Signaling, 2012, vol. 24, pp. 1297–1305.
Caceres, N., Tapia, G., Ojanguren, I., et al., Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models, Tuberculosis, 2009, vol. 89, pp. 175–182.
Cadwell, K. and Philips, J.A., Autophagy meets phagocytosis, Immunity, 2013, vol. 39, pp. 425–427.
Campbell, G.R. and Spector, S.A., Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy, PLoS Pathog., 2012, vol. 8, p. e1002689.
Chan, E.D., Chan, J., and Schluger, N.W., What is the role of nitric oxide in murine and human host defense against tuberculosis? Am. J. Respir. Cell Mol. Biol., 2001, vol. 25, pp. 606–612.
Chun, R.F., Adams, J.S., and Hewison, M., Immunomodulation by vitamin D: implications for TB, Expert Rev. Clin. Pharmacol., 2011, vol. 4, pp. 583–591.
Comas, I., Coscolla, M., Luo, T., et al., Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans, Nat. Genet., 2013, vol. 45, pp. 1176–1182.
Cooper, A.M. and Khader, S.A., The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis, Immunol. Rev., 2008, vol. 226, pp. 191–204.
Cyktor, J.C., Carruthers, B., Kominsky, R.A., et al., IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection, J. Immunol., 2013, vol. 190, pp. 2778–2790.
Date, D., Das, R., Narla, G., et al., Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization, J. Biol. Chem., 2014, vol. 289, pp. 10318–10329.
Davis, A.S., Vergne, I., Master, S.S., et al., Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes, PLoS Pathog., 2007, vol. 3, p. e186.
Delogu, G., Sali, M., and Fadda, G., The biology of mycobacterium tuberculosis infection, Medit. J. Hematol. Infect. Dis., 2013, vol. 5, p. e2013070.
Deretic, V., Autophagy in tuberculosis, Cold Spring Harb. Persp. Med., 2014, vol. 4, pp. 1–15.
Divangahi, M., Behar, S.M., and Remold, H., Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis, Adv. Exp. Med. Biol., 2013, vol. 783, pp. 103–120.
Dkhar, H.K., Nanduri, R., Mahajan, S., et al., Mycobacterium tuberculosis keto-mycolic acid and macrophage nuclear receptor TR4 modulate foamy biogenesis in granulomas: a case of a heterologous and noncanonical ligand-receptor pair, J. Immunol., 2014, vol. 193, pp. 295–305.
Dorhoi, A. and Kaufmann, S.H., Tumor necrosis factor alpha in mycobacterial infection, Semin. Immunol., 2014, vol. 26, pp. 203–209.
Dorozhkova, I.R., Tuberculosis pathogen: history of discovery and study, Tuberk. Bolezni Legk., 2012, no. 3, pp. 3–14.
Dushkin, M.I., Macrophage/foam cell is an attribute of inflammation: mechanisms of formation and functional role, Biochemistry (Moscow), 2012, vol. 77, no. 4, pp. 327–338.
Dyken van, S.J. and Locksley, R.M., Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease, Annu. Rev. Immunol., 2013, vol. 31, pp. 317–343.
Ehrt, S. and Schnappinger, D., Mycobacterial survival strategies in the phagosome: defense against host stresses, Cell. Microbiol., 2009, vol. 11, pp. 1170–1178.
El Kasmi, K.C., Qualls, J.E., Pesce, J.T., et al., Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens, Nat. Immunol., 2008, vol. 9, pp. 1399–1406.
Elks, P.M., Brizee, S., van der Vaart, M., et al., Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism, PLoS Pathog., 2013, vol. 9, p. e1003789.
Fallahi-Sichani, M., Kirschner, D.E., and Linderman, J.J., NF-κB signaling dynamics play a key role in infection control in tuberculosis, Front. Physiol., 2012, vol. 3, pp. 1–25.
Feng, Y., Dorhoi, A., Mollenkopf, H.J., et al., Platelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation, J. Infect. Dis., 2014, vol. 210, pp. 1700–1710.
Ferrante, C.J. and Leibovich, S.J., Regulation of macrophage polarization and wound healing, Adv. Wound Care, 2012, vol. 1, pp. 10–16.
Ferrari, C.K., Souto, P.C., Franca, E.L., and Honorio-Franca, A.C., Oxidative and nitrosative stress on phagocytes’ function: from effective defense to immunity evasion mechanisms, Arch. Immunol. Ther. Exp., 2011, vol. 59, pp. 441–448.
Frisdal, E., Lesnik, P., Olivier, M., et al., Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response, J. Biol. Chem., 2011, vol. 286, pp. 30926–30936.
Fujita, M., Harada, E., Matsumoto, T., et al., Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease, Clin. Exp. Immunol., 2010, vol. 160, pp. 457–460.
Galluzzi, L., Vitale, I., Abrams, J.M., et al., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, Cell Death Differ., 2012, vol. 19, pp. 107–120.
Gloire, G. and Piette, J., Redox regulation of nuclear posttranslational modifications during NF-κB activation, Antioxid. Redox Signaling, 2009, vol. 11, pp. 2209–2222.
Green, J.A., Elkington, P.T., Pennington, C.J., et al., Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-κB-and activator protein-1-dependent monocyte networks, J. Immunol., 2010, vol. 184, pp. 6492–6503.
Guirado, E., Schlesinger, L.S., and Kaplan, G., Macrophages in tuberculosis: friend or foe, Semin. Immunopathol., 2013, vol. 35, pp. 563–583.
Gupta, A., Kaul, A., Tsolaki, A.G., et al., Mycobacterium tuberculosis: immune evasion, latency and reactivation, Immunobiology, 2012, vol. 217, pp. 363–374.
Harris, J., Autophagy and cytokines, Cytokine, 2011, vol. 56, pp. 140–144.
Harris, J. and Keane, J., How tumor necrosis factor blockers interfere with tuberculosis immunity, Clin. Exp. Immunol., 2010, vol. 161, pp. 1–9.
Heitmann, L., Abad Dar, M., Schreiber, T., et al., The IL-13/IL-4Ra axis is involved in tuberculosis-associated pathology, J. Pathol., 2014, vol. 234, pp. 338–350.
Herbst, S., Schaible, U.E., and Schneider, B.E., Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis, PLoS One, 2011, vol. 6, p. e19105.
Hossain, M.M. and Norazmi, M.N., Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection-the double-edged sword? Biomed. Res. Int., 2013, vol. 2013, pp. 1–18.
Huynh, K.K., Joshi, S.A., and Brown, E.J., A delicate dance: host response to mycobacteria, Curr. Opin. Immunol., 2011, vol. 23, pp. 464–472.
Jain, A. and Singh, J.A., Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature, Immunotherapy, 2013, vol. 5, pp. 265–299.
Jo, E.K., Autophagy as an innate defense against mycobacteria, Pathog. Dis., 2013, vol. 67, pp. 108–118.
Juarez, E., Carranza, C., Hernandez-Sanchez, F., et al., NOD2 enhances the innate response of alveolar macrophages to Mycobacterium tuberculosis in humans, Eur. J. Immunol., 2012, vol. 42, pp. 880–889.
Jung, J.Y., Madan-Lala, R., Georgieva, M., et al., The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria, Infect. Immun., 2013, vol. 81, pp. 3198–3209.
Kadl, A., Meher, A.K., Sharma, P.R., et al., Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2, Circ. Res., 2010, vol. 107, pp. 737–746.
Kaufmann, S.H., Tuberculosis vaccines: time to think about the next generation, Semin. Immunol., 2013, vol. 25, pp. 172–181.
Kaufmann, S.H.E. and Dorhoi, A., Inflammation in tuberculosis: interactions, imbalances, and interventions, Curr. Opin. Immunol., 2013, vol. 25, pp. 441–449.
Keeton, R., Allie, N., Dambuza, I., et al., Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis, J. Clin. Invest., 2014, vol. 124, pp. 1537–1551.
Kim, J.J., Lee, H.M., Shin, D.M., et al., Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action, Cell Host Microbe, 2012, vol. 11, pp. 457–468.
Kim, K., Sohn, H., Kim, J.S., et al., Mycobacterium tuberculosis Rv0652 stimulates production of tumor necrosis factor and monocytes chemoattractant protein-1 in macrophages through the toll-like receptor 4 pathway, Immunology, 2012, vol. 136, pp. 231–240.
Kleinnijenhuis, J., Oosting, M., Joosten, L.A., et al., Innate immune recognition of Mycobacterium tuberculosis, Clin. Dev. Immunol., 2011, vol. 2011, pp. 1–12.
Kolpakova, T.A., The problem of co-morbidity in the course of bronchial tuberculosis, Byull. Vost.-Sib. Nauch. Tsentra, Sib. Otd., Ross. Akad. Med. Nauk, 2011, no. 2, pp. 48–51.
Korf, H., Vander Beken, S., Romano, M., et al., Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice, J. Clin. Invest., 2009, vol. 119, pp. 1626–1637.
Krasnov, V.A., Zenkov, N.K., Kolpakov, A.R., and Menshchikova, E.B., Activated oxygen metabolites at tuberculosis, Probl. Tuberk. Bolezn. Legk., 2005, no. 9, pp. 9–16.
Kumar, A., Farhana, A., Guidry, L., et al., Redox homeostasis in mycobacteria: the key to tuberculosis control? Expert Rev. Mol. Med., 2011, vol. 13, p. e39.
Lalvani, A. and Pareek, M., Interferon gamma release assays: principles and practice, Enferm. Infecc. Microbiol. Clin., 2010, vol. 28, pp. 245–252.
Liao, D., Fan, Q., and Bao, L., The role of superoxide dismutase in the survival of Mycobacterium tuberculosis in macrophages, Jpn. J. Infect. Dis., 2013, vol. 66, pp. 480–488.
Liao, X., Sharma, N., Kapadia, F., et al., Kruppel-like factor 4 regulates macrophage polarization, J. Clin. Invest., 2011, vol. 121, pp. 2736–2749.
Liu, P.T., Stenger, S., Li, H., et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science, 2006, vol. 311, pp. 1770–1773.
Liu, W., Peng, Y., Yin, Y., et al., The involvement of NADPH oxidase-mediated ROS in cytokine secretion from macrophages induced by Mycobacterium tuberculosis ESAT-6, Inflammation, 2014, vol. 37, pp. 880–892.
Locati, M., Mantovani, A., and Sica, A., Macrophage activation and polarization as an adaptive component of innate immunity, Adv. Immunol., 2013, vol. 120, pp. 163–184.
Lugo-Villarino, G., Hudrisier, D., Benard, A., and Neyrolles, O., Emerging trends in the formation and function of tuberculosis granulomas, Front. Immunol., 2012, vol. 3, pp. 1–9.
Lugo-Villarino, G. and Neyrolles, O., Manipulation of the mononuclear phagocyte system by Mycobacterium tuberculosis, Cold Spring Harbor Perspect. Med., 2014, vol. 4, pp. 1–14.
Luzina, I.G., Keegan, A.D., Heller, N.M., et al., Regulation of inflammation by interleukin-4: a review of “alternatives,” J. Leukocyte Biol., 2012, vol. 92, pp. 753–764.
Mackaness, G.B., The immunological basis of acquired cellular resistance, J. Exp. Med., 1964, vol. 120, pp. 105–120.
Mahajan, S., Dkhar, H.K., Chandra, V., et al., Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPAR? and TR4 for survival, J. Immunol., 2012, vol. 188, pp. 5593–5603.
Martens, G.W., Vallerskog, T., and Kornfeld, H., Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity, J. Leukocyte Biol., 2012, vol. 91, pp. 849–857.
Martin, C.J., Booty, M.G., Rosebrock, T.R., et al., Efferocytosis is an innate antibacterial mechanism, Cell Host Microbe, 2012, vol. 12, pp. 289–300.
Martinez, F.O. and Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment, F1000Prime Rep., 2014, vol. 6, pp. 1–13.
Mattila, J.T., Ojo, O.O., Kepka-Lenhart, D., et al., Microenvironments in tuberculosis granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms, J. Immunol., 2013, vol. 191, pp. 773–784.
Means, T.K., Jones, B.W., Schromm, A.B., et al., Differential effects of a toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses, J. Immunol., 2001, vol. 166, pp. 4074–4082.
Melo, R.C., D’Avila, H., Wan, H.C., et al., Lipid bodies in inflammatory cells: structure, function, and current imaging techniques, J. Histochem. Cytochem., 2011, vol. 59, pp. 540–556.
Menshchikova, E.B., Zenkov, N.K., Lankin, V.Z., et al., Okislitel’nyi stress. Patologicheskie sostoyaniya i zabolevaniya (Oxidative Stress. Pathological States and Diseases), Novosibirsk: ARTA, 2008.
Mizuno, S., Yamamoto, M., and Sugawara, I., Significant reduction of granulomas in Nrf2-deficient mice infected with Mycobacterium tuberculosis, Indian J. Tuberc., 2010, vol. 57, pp. 108–113.
Molloy, A., Laochumroonvorapong, P., and Kaplan, G., Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin, J. Exp. Med., 1994, vol. 180, pp. 1499–1509.
Monastyrskaya, E.A., Lyamina, S.V., and Malyshev, I.Yu., M1 and M2 phenotypes of activated macrophages and their role in immune response and pathology, Patogenez, 2008, vol. 6, no. 4, pp. 31–39.
Moreno, J.L., Mikhailenko, I., Tondravi, M.M., and Keegan, A.D., IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin, J. Leukocyte Biol., 2007, vol. 82, pp. 1542–1553.
Nasonov, E.L., Koslov, R.S., and Yakushin, S.B., Infectious complications in the therapy by inhibitor of tumor necrosis factor, Klin. Mikrobiol. Antimikrob. Khimioter., 2006, vol. 8, no. 4, pp. 314–324.
Newton-Foot, M. and Gey van Pittius, N.C., The complex architecture of mycobacterial promoters, Tuberculosis, 2013, vol. 93, pp. 60–74.
Oh, J.E. and Lee, H.K., Pattern recognition receptors and autophagy, Front. Immunol., 2014, vol. 5, pp. 1–7.
Olobo, J.O., Geletu, M., Demissie, A., et al., Circulating TNF-a, TGF-β, and IL-10 in tuberculosis patients and healthy contacts, Scand. J. Immunol., 2001, vol. 53, pp. 85–91.
Onoprienko, L.V., Molecular mechanisms of regulation of the macrophage activity, Russ. J. Bioorg. Chem., 2011, vol. 37, no. 4, pp. 387–399.
Ouellet, H., Johnston, J.B., and de Montellano, P.R., Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis, Trends Microbiol., 2011, vol. 19, pp. 530–539.
Palanisamy, G.S., Kirk, N.M., Ackart, D.F., et al., Evidence for oxidative stress and defective antioxidant response in Guinea pigs with tuberculosis, PLoS One, 2011, vol. 6, p. e26254.
Parandhaman, D.K. and Narayanan, S., Cell death paradigms in the pathogenesis of Mycobacterium tuberculosis infection, Front. Cell. Infect. Microbiol., 2014, vol. 4, pp. 1–7.
Parkash, O., Vaccine against tuberculosis: a view, J. Med. Microbiol., 2014, vol. 63, pp. 777–779.
Pearl, J.E., Saunders, B., Ehlers, S., et al., Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse, Cell. Immunol., 2001, vol. 211, pp. 43–50.
Perez-Guzman, C., Vargas, M.H., Quinonez, F., et al., A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis, Chest, 2005, vol. 127, pp. 643–651.
Pesce, J., Kaviratne, M., Ramalingam, T.R., et al., The IL-21 receptor augments Th2 effector function and alternative macrophage activation, J. Clin. Invest., 2006, vol. 116, pp. 2044–2055.
Pessanha, A.P., Martins, R.A., Mattos-Guaraldi, A.L., et al., Arginase-1 expression in granulomas of tuberculosis patients, FEMS Immunol. Med. Microbiol., 2012, vol. 66, pp. 265–268.
Peyron, P., Vaubourgeix, J., Poquet, Y., et al., Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence, PLoS Patog., 2008, vol. 4, p. e1000204.
Pfeffer, L.M., The role of nuclear factor B in the interferon response, J. Interferon Cytokine Res., 2011, vol. 31, pp. 553–559.
Pichugin, A.V. and Apt, A.S., Cell apoptosis of immune system at tuberculosis infection, Probl. Tuberk. Bolezn. Legk., 2005, no. 12, pp. 3–7.
Polvani, S., Tarocchi, M., and Galli, A., PPAR? and oxidative stress: Con(β) catenating NRF2 and FOXO, PPAR Res., 2012, vol. 2012, pp. 1–15.
Ponpuak, M., Davis, A.S., Roberts, E.A., et al., Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties, Immunity, 2010, vol. 32, pp. 329–341.
Qualls, J.E., Neale, G., Smith, A.M., et al., Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling, Sci. Signaling, 2010, vol. 3, pp. 1–16.
Redente, E.F., Higgins, D.M., Dwyer-Nield, L.D., et al., Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation, J. Leukocyte Biol., 2010, vol. 88, pp. 159–168.
Redford, P.S., Boonstra, A., Read, S., et al., Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung, Eur. J. Immunol., 2010, vol. 40, pp. 2200–2210.
Redford, P.S., Murray, P.J., and O’Garra, A., The role of IL-10 in immune regulation during M. tuberculosis infection, Mucosal Immunol., 2011, vol. 4, pp. 261–270.
Roca, F.J. and Ramakrishnan, L., TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species, Cell, 2013, vol. 153, pp. 521–534.
Sahin, F. and Yildiz, P., Distinctive biochemical changes in pulmonary tuberculosis and pneumonia, Arch. Med. Sci., 2013, vol. 9, pp. 656–661.
Sakhno, L.V. and Chernykh, E.R., Antigen-producing cells at the bronchial tuberculosis, Tuberk. Bolezni Legk., 2012, no. 1, pp. 3–9.
Salamon, H., Bruiners, N., Lakehal, K., et al., Cutting edge: vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection, J. Immunol., 2014, vol. 193, pp. 30–34.
Sanjurjo, L., Amezaga, N., Vilaplana, C., et al., The scavenger protein apoptosis inhibitor of macrophages (AIM) potentiates the antimicrobial response against Mycobacterium tuberculosis by enhancing autophagy, PLoS One, 2013, vol. 8, p. e79670.
Shaler, C.R., Horvath, C.N., Jeyanathan, M., and Xing, Z., Within the enemy’s camp: contribution of the granuloma to the dissemination, persistence, and transmission of Mycobacterium tuberculosis, Front. Immunol., 2013, vol. 4, pp. 1–8.
Sica, A. and Mantovani, A., Macrophage plasticity and polarization: in vivo veritas, J. Clin. Invest., 2012, vol. 122, pp. 787–795.
Sigidin, Ya.A. and Lukina, G.V., The risk of tuberculosis development at the implementation of inhibitors of alpha-tumor necrosis factor, Russ. Med. Zh., 2009, no. 21, pp. 1438–1442.
Singh, V., Jamwal, S., Jain, R., et al., Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype, Cell Host Microbe, 2012, vol. 12, pp. 669–681.
Songane, M., Kleinnijenhuis, J., Netea, M.G., and van Crevel, R., The role of autophagy in host defense against Mycobacterium tuberculosis infection, Tuberculosis, 2012, vol. 92, pp. 388–396.
Sridharan, H. and Upton, J.W., Programmed necrosis in microbial pathogenesis, Trends Microbiol., 2014, vol. 22, pp. 199–207.
Srinivasan, L., Ahlbrand, S., and Briken, V., Interaction of Mycobacterium tuberculosis with host cell death pathways, Cold Spring Harbor Persp. Med., 2014, vol. 4, pp. 1–15.
Stanley, S.A. and Cox, J.S., Host-pathogen interactions during Mycobacterium tuberculosis infections, Curr. Top. Microbiol. Immunol., 2013, vol. 374, pp. 211–241.
Stein, M., Keshav, S., Harris, N., and Gordon, S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J. Exp. Med., 1992, vol. 176, pp. 287–292.
Striz, I., Brabcova, E., Kolesar, L., and Sekerkova, A., Cytokine networking of innate immunity cells: a potential target of therapy, Clin. Sci., 2014, vol. 126, pp. 593–612.
Sukhanov, D.S., Immunotropic therapy of tuberculosis infection, Ter. Arkh., 2013, no. 3, pp. 110–117.
Szanto, A., Balint, B.L., Nagy, Z.S., et al., STAT6 transcription factor is a facilitator of the nuclear receptor PPAR?-regulated gene expression in macrophages and dendritic cells, Immunity, 2010, vol. 33, pp. 699–712.
Takeda, N., O’Dea, E.L., Doedens, A., et al., Differential activation and antagonistic function of HIF-a isoforms in macrophages are essential for NOhomeostasis, Genes Dev., 2010, vol. 24, pp. 491–501.
Taylor, J.L., Hattle, J.M., Dreitz, S.A., et al., Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection, Infect. Immun., 2006, vol. 74, pp. 6135–6144.
Torun, E., Gedik, A.H., Cakir, E., et al., Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis, Med. Princ. Pract., 2014, vol. 23, pp. 1–7.
Tugal, D., Liao, X., and Jain, M.K., Transcriptional control of macrophage polarization, Arterioscler., Thromb., Vasc. Biol., 2013, vol. 33, pp. 1135–1144.
Walford, H.H. and Doherty, T.A., STAT6 and lung inflammation, JAK-STAT, 2013, vol. 2, p. e25301.
Winthrop, K.L. and Iseman, M., Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy, Nat. Rev. Rheumatol., 2013, vol. 9, pp. 524–531.
Xiao, X. and Song, B.L., SREBP: a novel therapeutic target, Acta Biochim. Biophys. Sin., 2013, vol. 45, pp. 2–10.
Xu, G., Wang, J., Gao, G.F., and Liu, C.H., Insights into battles between Mycobacterium tuberculosis and macrophages, Protein Cell, 2014, vol. 5, pp. 728–736.
Yang, C.S., Shin, D.M., Kim, K.H., et al., NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression, J. Immunol., 2009, vol. 182, pp. 3696–3705.
Yang, C.S., Yuk, J.M., and Jo, E.K., The role of nitric oxide in mycobacterial infections, Immune Network, 2009, vol. 9, pp. 46–52.
Yu, X., Li, C., Hong, W., et al., Autophagy during Mycobacterium tuberculosis infection and implications for future tuberculosis medications, Cell. Signaling, 2013, vol. 25, pp. 1272–1278.
Zenkov, N.K., Menshchikova, E.B., and Shkurupii, V.A., Triggering mechanism of macrophages, Usp. Sovrem. Biol., 2007, vol. 127, no. 3, pp. 243–256.
Zenkov, N.K., Menshchikova, E.B., and Tkachev, V.O., Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target, Biochemistry (Moscow), 2013, vol. 78, no. 1, pp. 19–36.
Zuniga, J., Torres-Garcia, D., Santos-Mendoza, T., et al., Cellular and humoral mechanisms involved in the control of tuberculosis, Clin. Dev. Immunol., 2012, vol. 2012, pp. 1–18.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.K. Zenkov, A.V. Chechushkov, P.M. Kozhin, T.A. Kolpakova, E.B. Menshchikova, 2015, published in Uspekhi Sovremennoi Biologii, 2015, Vol. 135, No. 6, pp. 554–574.
Rights and permissions
About this article
Cite this article
Zenkov, N.K., Chechushkov, A.V., Kozhin, P.M. et al. Macrophage and Mycobacterium: The war without beginning or end. Biol Bull Rev 6, 289–308 (2016). https://doi.org/10.1134/S2079086416040095
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079086416040095